SLN
Silence Therapeutics plc
NASDAQ · GBHealthcareBiotechnology
$10.49-0.10%
Price as of Jul 20, 2026
SLN valuation
Silence Therapeutics plc valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 69.76x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 10.03x
- Price / sales
- 537.71x
- Price / cash flow
- -7.56x
Enterprise value
- Enterprise value
- $425.5M
- EV / sales
- 461.81x
- EV / EBITDA
- -5.45x
- EV / EBIT
- -4.91x
- Market cap
- $495.5M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.